Michael D. Witzeman - 13 Feb 2026 Form 4 Insider Report for CHEMED CORP (CHE)

Role: VP & Chief Financial Officer
Signature: Michael D. Witzeman
Issuer symbol: CHE
Transactions as of: 13 Feb 2026
Net transactions value: +$137,581
Form type: 4
Filing time: 17 Feb 2026, 15:37:01 UTC
Previous filing: 22 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Witzeman Michael D	VP & Chief Financial Officer	2600 CHEMED CENTER, 255 EAST FIFTH STREET, CINCINNATI	Michael D. Witzeman	17 Feb 2026	0001699624

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CHE	Capital Stock	Options Exercise	$193,928	+413	+7.3%	$469.56	6,073	13 Feb 2026	Direct	F1
transaction	CHE	Capital Stock	Options Exercise	$0	0	0%	$469.56	6,073	13 Feb 2026	Direct	F2
transaction	CHE	Capital Stock	Tax liability	$56,347	-120	-2%	$469.56	5,953	13 Feb 2026	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CHE	Performance Stock Units	Options Exercise	$0	-333	-12%	$0.000000	2,403	13 Feb 2026	Capital Stock	333		Direct	F4, F5
transaction	CHE	Performance Stock Units	Options Exercise	$0	-333	-14%	$0.000000	2,070	13 Feb 2026	Capital Stock	333		Direct	F4, F5
transaction	CHE	Performance Stock Units	Award	$0	+1,394	+67%	$0.000000	3,464	13 Feb 2026	Capital Stock	1,394		Direct	F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target.
F2	The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target.
F3	Shares withheld to satisfy tax obligations in connection with vesting of PSUs.
F4	Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.
F5	PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.
F6	Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock
F7	Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter.